Pakistan Synthetics Limited (PSX:PSYL)
Pakistan · Delayed Price · Currency is PKR 95.68
+8.70 (10.00%)
At close: Jun 1, 2026
Pakistan Synthetics Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 15,301 | 16,872 | 13,800 | 14,425 | 12,311 | 7,251 | |
Revenue Growth (YoY) | -8.22% | 22.27% | -4.34% | 17.17% | 69.80% | 10.07% |
Cost of Revenue | 13,330 | 14,901 | 11,730 | 11,851 | 9,991 | 5,800 |
Gross Profit | 1,971 | 1,971 | 2,070 | 2,574 | 2,320 | 1,451 |
Selling, General & Admin | 346.75 | 377.25 | 438.02 | 496.05 | 329.67 | 203.15 |
Other Operating Expenses | 126.81 | 47.21 | 45.67 | 139.58 | 111.15 | 52.24 |
Operating Expenses | 487.26 | 438.16 | 392.77 | 635.63 | 481.12 | 243.46 |
Operating Income | 1,484 | 1,533 | 1,677 | 1,939 | 1,839 | 1,207 |
Interest Expense | -567.17 | -653.35 | -834.12 | -373.94 | -244.13 | -184.19 |
Interest & Investment Income | 1.47 | 1.47 | 2.55 | 6.13 | 15.76 | 0.19 |
Earnings From Equity Investments | -142.13 | -204.55 | -318.92 | - | - | - |
Currency Exchange Gain (Loss) | -52.82 | -52.82 | 7.43 | -220.56 | -150.63 | 29.61 |
Other Non Operating Income (Expenses) | 28.12 | 13.79 | 19.57 | 24.2 | 23.55 | -5.27 |
EBT Excluding Unusual Items | 751.58 | 637.5 | 553.34 | 1,375 | 1,484 | 1,048 |
Gain (Loss) on Sale of Investments | -3.02 | -3.02 | 4.23 | -3.75 | -6.62 | 0.03 |
Gain (Loss) on Sale of Assets | 3 | 3 | 0.09 | 1.17 | 4.19 | 3.47 |
Other Unusual Items | - | - | - | - | - | 4.11 |
Pretax Income | 751.55 | 637.48 | 557.66 | 1,372 | 1,481 | 1,055 |
Income Tax Expense | 282.23 | 270.02 | 209.9 | 574.38 | 494.93 | 307.07 |
Earnings From Continuing Operations | 469.32 | 367.45 | 347.77 | 797.68 | 986.21 | 748.37 |
Net Income | 469.32 | 367.45 | 347.77 | 797.68 | 986.21 | 748.37 |
Net Income to Common | 469.32 | 367.45 | 347.77 | 797.68 | 986.21 | 748.37 |
Net Income Growth | 64.78% | 5.66% | -56.40% | -19.12% | 31.78% | - |
Shares Outstanding (Basic) | 139 | 139 | 139 | 139 | 139 | 139 |
Shares Outstanding (Diluted) | 139 | 139 | 139 | 139 | 139 | 139 |
Shares Change (YoY) | - | - | - | - | - | 17.58% |
EPS (Basic) | 3.38 | 2.65 | 2.51 | 5.75 | 7.11 | 5.40 |
EPS (Diluted) | 3.38 | 2.65 | 2.51 | 5.75 | 7.11 | 5.40 |
EPS Growth | 64.78% | 5.66% | -56.40% | -19.12% | 31.78% | - |
Free Cash Flow | -496.3 | 1,234 | -2,064 | 1,147 | -434.53 | 602.58 |
Free Cash Flow Per Share | -3.58 | 8.90 | -14.88 | 8.27 | -3.13 | 4.34 |
Dividend Per Share | - | - | - | - | - | 1.515 |
Gross Margin | 12.88% | 11.68% | 15.00% | 17.85% | 18.85% | 20.01% |
Operating Margin | 9.70% | 9.09% | 12.15% | 13.44% | 14.94% | 16.65% |
Profit Margin | 3.07% | 2.18% | 2.52% | 5.53% | 8.01% | 10.32% |
Free Cash Flow Margin | -3.24% | 7.31% | -14.96% | 7.95% | -3.53% | 8.31% |
EBITDA | 2,002 | 2,000 | 2,104 | 2,346 | 2,170 | 1,460 |
EBITDA Margin | 13.08% | 11.85% | 15.25% | 16.26% | 17.63% | 20.14% |
D&A For EBITDA | 517.96 | 466.95 | 427.11 | 407.27 | 331.48 | 252.78 |
EBIT | 1,484 | 1,533 | 1,677 | 1,939 | 1,839 | 1,207 |
EBIT Margin | 9.70% | 9.09% | 12.15% | 13.44% | 14.94% | 16.65% |
Effective Tax Rate | 37.55% | 42.36% | 37.64% | 41.86% | 33.42% | 29.09% |